Molina Healthcare (NYSE:MOH) PT Lowered to $412.00

Molina Healthcare (NYSE:MOH) had its price objective lowered by investment analysts at TD Cowen from $453.00 to $412.00 in a note issued to investors on Tuesday, Benzinga reports. The firm currently has a “buy” rating on the stock. TD Cowen’s price objective indicates a potential upside of 21.58% from the company’s previous close.

A number of other research firms have also commented on MOH. Truist Financial upped their price objective on shares of Molina Healthcare from $435.00 to $460.00 and gave the company a “buy” rating in a research note on Tuesday, February 20th. Cantor Fitzgerald reissued an “overweight” rating and set a $406.00 target price on shares of Molina Healthcare in a research note on Thursday, April 4th. StockNews.com lowered Molina Healthcare from a “strong-buy” rating to a “buy” rating in a report on Thursday, February 8th. Wells Fargo & Company lowered their price target on Molina Healthcare from $410.00 to $375.00 and set an “equal weight” rating on the stock in a report on Monday. Finally, Stephens reissued an “equal weight” rating and issued a $390.00 price objective on shares of Molina Healthcare in a research note on Thursday, April 25th. One analyst has rated the stock with a sell rating, four have given a hold rating and six have issued a buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $398.55.

Molina Healthcare Stock Down 0.9 %

MOH stock opened at $338.87 on Tuesday. The firm has a market cap of $19.86 billion, a PE ratio of 18.39, a P/E/G ratio of 0.97 and a beta of 0.47. Molina Healthcare has a 12 month low of $266.35 and a 12 month high of $423.92. The company has a debt-to-equity ratio of 0.53, a current ratio of 1.49 and a quick ratio of 1.49. The firm has a 50 day simple moving average of $386.79 and a 200 day simple moving average of $372.10.

Molina Healthcare (NYSE:MOH) last released its quarterly earnings data on Wednesday, April 24th. The company reported $5.73 earnings per share for the quarter, topping the consensus estimate of $5.46 by $0.27. The business had revenue of $9.93 billion during the quarter, compared to analyst estimates of $9.45 billion. Molina Healthcare had a return on equity of 29.86% and a net margin of 2.99%. The company’s revenue was up 21.9% compared to the same quarter last year. During the same period last year, the company posted $5.81 EPS. Equities research analysts forecast that Molina Healthcare will post 23.59 earnings per share for the current fiscal year.

Insider Transactions at Molina Healthcare

In related news, Director Richard M. Schapiro sold 711 shares of the business’s stock in a transaction that occurred on Monday, February 12th. The stock was sold at an average price of $384.06, for a total value of $273,066.66. Following the completion of the sale, the director now owns 12,207 shares of the company’s stock, valued at approximately $4,688,220.42. The sale was disclosed in a document filed with the SEC, which is available at this link. In other Molina Healthcare news, CFO Mark Lowell Keim sold 15,000 shares of the business’s stock in a transaction dated Monday, February 12th. The stock was sold at an average price of $386.56, for a total value of $5,798,400.00. Following the completion of the sale, the chief financial officer now owns 36,531 shares of the company’s stock, valued at $14,121,423.36. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, Director Richard M. Schapiro sold 711 shares of the stock in a transaction dated Monday, February 12th. The shares were sold at an average price of $384.06, for a total value of $273,066.66. Following the transaction, the director now directly owns 12,207 shares in the company, valued at approximately $4,688,220.42. The disclosure for this sale can be found here. Insiders sold 16,711 shares of company stock valued at $6,472,517 in the last three months. Corporate insiders own 1.11% of the company’s stock.

Institutional Investors Weigh In On Molina Healthcare

A number of large investors have recently added to or reduced their stakes in the stock. Annis Gardner Whiting Capital Advisors LLC bought a new position in shares of Molina Healthcare in the third quarter valued at approximately $30,000. McIlrath & Eck LLC bought a new position in Molina Healthcare in the 4th quarter worth $34,000. VisionPoint Advisory Group LLC lifted its position in Molina Healthcare by 105.6% during the 3rd quarter. VisionPoint Advisory Group LLC now owns 111 shares of the company’s stock worth $36,000 after acquiring an additional 57 shares during the last quarter. Principal Securities Inc. bought a new stake in Molina Healthcare during the fourth quarter valued at about $42,000. Finally, Friedenthal Financial acquired a new stake in shares of Molina Healthcare in the fourth quarter valued at about $43,000. Institutional investors own 98.50% of the company’s stock.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.